Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ]: Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Thu, September 9, 2010
Wed, September 8, 2010
Tue, September 7, 2010
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ]: Market Wire
Transdel Pharmaceuticals
Fri, September 3, 2010
Thu, September 2, 2010
Wed, September 1, 2010
Tue, August 31, 2010
Mon, August 30, 2010
Sun, August 29, 2010
Fri, August 27, 2010
[ Fri, Aug 27th 2010 ]: Market Wire
?????????????????????
Thu, August 26, 2010

Ryan & Maniskas, LLP Announces Investigation of ZymoGenetics, Inc.


  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. announces-investigation-of-zymogenetics-inc.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


WAYNE, Pa.--([ BUSINESS WIRE ])--Ryan & Maniskas, LLP ([ www.rmclasslaw.com/cases/zgen ]) is investigating potential claims against the board of directors of ZymoGenetics, Inc. ("ZymoGenetics" or the "Company") (NASDAQ: ZGEN) concerning possible breaches of fiduciary duty and other violations of law related to the Companya™s efforts to sell ZymoGenetics to Bristol-Myers Squibb Company.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Companya™s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of ZymoGenetics. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at [ rmaniskas@rmclasslaw.com ] or visit: [ www.rmclasslaw.com/cases/zgen ].

Under the terms of the announced tender offer, ZymoGenetics shareholders will receive $9.75 in cash for each share of ZymoGenetics they own if the tender offer is completed. The companies expect the tender offer to close approximately thirty days after commencement of the tender offer on or about September 9, 2010.

If you own shares of ZymoGenetics and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: [ www.rmclasslaw.com/cases/zgen ]. You may also email Mr. Maniskas at [ rmaniskas@rmclasslaw.com ]. For more information about class action cases in general, please visit our website: [ www.rmclasslaw.com ].

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan and Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear